Identifying new therapeutic uses for approved drugs known as drug repositioning can reduce development costs and accelerate regulatory approval. Two recent studies, led by the same group of researchers, used computational analysis of publicly available gene expression data to suggest potential new therapeutic
CITATION STYLE
Harrison, C. (2011). Signatures for drug repositioning. Nature Reviews Genetics, 12(10), 669–669. https://doi.org/10.1038/nrg3076
Mendeley helps you to discover research relevant for your work.